Skip to main content
. Author manuscript; available in PMC: 2012 Jan 23.
Published in final edited form as: Transplantation. 2011 Aug 15;92(3):359–365. doi: 10.1097/TP.0b013e3182244cc3

FIGURE 1.

FIGURE 1

Sustained CD4+ T-cell response to DBY after allogeneic hematopoietic stem-cell transplantation (HSCT). (A) ELISPOT assays for IFN-γ secretion were conducted using ex vivo peripheral blood mononuclear cells(PBMC)collected 31 months after HSCT stimulated with overlapping DBY peptides. (B) ELISPOT assays for IFN-γ secretion were carried out using ex vivo PBMC collected serially between 18 and 38 months after HSCT stimulated with DBY 427–444. Results are expressed as number of spots per 106 cells.